An interventional study of Epidural Block and Pericapsular Nerve Group Block (PENG Block) in Total Hip Arthroplasty (THA) and Postoperative Pain Management, sponsored by Bangladesh Medical University. Not yet recruiting at 1 site in Bangladesh. Open to participants aged 18 Years to 64 Years. Per ClinicalTrials.gov, last updated 2026-11-16.
Sponsored by Bangladesh Medical University · Not applicable, Interventional, and Treatment
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
This study aims to compare the effectiveness of ultrasound-guided Pericapsular Nerve Group (PENG) block and epidural block for postoperative analgesia in patients undergoing elective unilateral total hip arthroplasty. A total of 62 eligible patients will be randomly allocated into two groups: Group A will receive epidural block, and Group B will receive PENG block. Postoperative pain scores, opioid consumption, time to first rescue analgesia, motor blockade, adverse effects, and time to mobilization will be assessed to compare the analgesic efficacy and recovery outcomes of the two techniques.
Postoperative pain management is an important component of recovery following total hip arthroplasty. Epidural analgesia is an established regional anesthesia technique, whereas ultrasound-guided Pericapsular Nerve Group (PENG) block is a newer technique intended to provide targeted analgesia to the hip joint.
This single-blind, randomized controlled trial will compare these two techniques in 62 patients undergoing elective unilateral total hip arthroplasty at Bangladesh Medical University, Dhaka, Bangladesh.
Participants will be randomly assigned in a 1:1 ratio to receive either an epidural block or a PENG block. Both groups will receive standardized postoperative multimodal analgesia. Pain intensity will be assessed using the Numeric Rating Scale (NRS) at 0, 2, 4, 6, 12 and 24 hours after surgery. Additional outcomes will include total opioid consumption, time to first rescue analgesia, motor blockade, adverse effects, and time to mobilization.
The findings will help compare the analgesic effectiveness and postoperative recovery associated with these two regional anesthesia techniques.
5,654 studies on the registry are indexed under Pain, Postoperative; 1,233 are open to participants now.
This study's planned enrollment of 62 is below the median of 75 across 4,835 interventional studies indexed under Pain, Postoperative.
Browse Pain, Postoperative studies →Bangladesh Medical University is the lead sponsor of 45 studies on the registry; 27 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
The anaesthetists’ scale of health before surgery: I is healthy, II has a mild illness that is under control, III a severe one, IV a severe illness that is a constant threat to life. V and VI are used for the critically ill and for organ donors.
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Blood tests of how long blood takes to clot. The INR is the prothrombin time (PT) put on a common scale; about 1 is usual for someone not taking a blood thinner.
Criteria often make an exception for people on a blood thinner such as warfarin, whose INR is raised on purpose.
Blood cells that help blood clot. Too few raises the risk of bleeding and bruising. A usual adult range is about 150–400 × 10⁹/L (150,000–400,000 per µL); each lab has its own reference range.
ASA physical status
The anaesthetists’ scale of health before surgery: I is healthy, II has a mild illness that is under control, III a severe one, IV a severe illness that is a constant threat to life. V and VI are used for the critically ill and for organ donors.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Informed consent
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
INR, PT and aPTT (clotting tests)
Blood tests of how long blood takes to clot. The INR is the prothrombin time (PT) put on a common scale; about 1 is usual for someone not taking a blood thinner.
Criteria often make an exception for people on a blood thinner such as warfarin, whose INR is raised on purpose.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Platelets
Blood cells that help blood clot. Too few raises the risk of bleeding and bruising. A usual adult range is about 150–400 × 10⁹/L (150,000–400,000 per µL); each lab has its own reference range.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Participants will receive an epidural block before spinal anaesthesia using an 18G Tuohy needle at L2-L3 or L3-L4, followed by a test dose with 3 mL of 2% lidocaine with adrenaline and 15-20 mL of 0.25% bupivacaine.
Procedure: Epidural Block
Participants will receive an ultrasound-guided PENG block in the supine position before spinal anaesthesia, using a 22-gauge needle and 20 mL of 0.25% bupivacaine.
Procedure: Pericapsular Nerve Group Block (PENG Block)
Participants will receive an epidural block before spinal anaesthesia using an 18G Tuohy needle at L2-L3 or L3-L4, followed by a test dose and 15-20 mL of 0.25% bupivacaine.
Participants will receive an ultrasound-guided Pericapsular Nerve Group Block (PENG) block before induction in the supine position, using a 22G needle and 20 mL of 0.25% bupivacaine.
Postoperative pain score at rest and on movement using the Numeric Rating Scale (NRS)
Pain intensity will be assessed using a 10-cm Numeric Rating Scale (NRS). The scale ranges from 0 to 10 cm, where 0 cm indicates no pain and 10 cm indicates the worst imaginable pain. Higher scores indicate greater pain intensity.
Time frame: At the recovery room- 0, 2, 4, 6, 12 and 24 hours after surgery
Time to First Rescue Analgesia
Time from completion of surgery to the first administration of rescue analgesia (intravenous morphine 0.05 mg/kg when the Numeric Rating Scale pain score is 4 or higher). The time will be recorded in minutes.
Time frame: Within 24 hours after surgery
Total Opioid Consumption
Total amount of intravenous morphine administered as rescue analgesia to each participant during the first 24 hours after surgery, measured in milligrams (mg).T
Time frame: Time Frame: First 24 hours after surgery.
Postoperative Motor Blockade
Motor blockade will be assessed using the Modified Bromage Scale, ranging from 0 to 3. A score of 0 indicates no motor block, while a score of 3 indicates complete motor block with inability to move the hip, knee, and ankle. Higher scores indicate greater motor blockade.
Time frame: At the recovery room- 0, 2, 6 hours after surgery
Postoperative Adverse Effects
Description: The occurrence of postoperative adverse effects, including hypotension, nausea, vomiting, and urinary retention, will be recorded for each participant. Each adverse effect will be documented as present or absent.
Time frame: First 24 hours after surgery
Time to First Mobilization
Time from surgery completion until the participant first stands or walks. The time will be recorded in minutes.
Time frame: Within 24 hours after surgery
Plan to share: No
Start is estimated for Dec 2026; primary completion for May 2027, 5 months later.
Of 2,097 non-industry interventional studies with no phase under Pain, Postoperative, half reached primary completion within 11 months of starting (the median), counting those still running; a quarter within 6 and three quarters within 23. This study's planned 5 months is below that.
Counting every sponsor, half of 2,110 studies reached it within 11 months; a quarter within 6 and three quarters within 23.
How these figures are worked out, and which studies are left out of them.
From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗
This study is not yet recruiting, as verified in Nov 2026. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Bangladesh Medical University